Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Assess How the Body Absorbs ABBV-8736 Subcutaneous Injections Relative to Intravenous Injections in Adult Healthy Volunteers
Sponsor: AbbVie
Summary
The purpose of this study is to assess the pharmacokinetics (PK), bioavailability, immunogenicity, safety, and tolerability of ABBV-8736 following subcutaneous (SC) administration relative to intravenous (IV) administration.
Official title: A Phase 1 Pharmacokinetic Study in Healthy Adult Volunteers to Evaluate the Bioavailability of ABBV-8736 Following Subcutaneous Administration Relative to Intravenous Administration
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2026-02-11
Completion Date
2026-06
Last Updated
2026-03-04
Healthy Volunteers
Yes
Conditions
Interventions
ABBV-8736
Intravenous Injection
ABBV-8736
Subcutaneous Injection
Locations (2)
CenExel ACT- Anaheim Clinical Trials /ID# 280481
Anaheim, California, United States
Acpru /Id# 280382
Grayslake, Illinois, United States